Xcene Research has reiterated the need for Sub-Saharan Africa (SSA) to play a more significant role in global clinical trials, emphasising its potential to address healthcare disparities, drive economic growth, and accelerate the development of innovative treatments.
This call was made at the 2024 Impact Africa Summit (IAS), held recently at the Marriott Hotel, Ikeja, Lagos.
Speaking at the summit, Adebukunola Telufusi, convener of IAS, described the platform as pivotal in championing clinical trials across Africa She noted, “Africa is experiencing a paradigm shift towards harnessing the power of science and research.
“By bolstering local partnerships and advocating for active participation, we can cultivate an environment that propels medical research forward, ultimately enhancing healthcare outcomes for communities across Africa.”
Dr Faramola Ogunkoya, project lead at Xcene Research, highlighted the summit’s comprehensive programme, which included workshops, symposiums, and market exchange forums addressing topics such as hematology, nephrology, regulatory practices, clinical operations, and patient advocacy.
“This conference transcends dialogue; it is a catalyst for tangible change in the realm of clinical trials, bringing us one stride closer to a healthier, more inclusive future for all,” she remarked.
The summit has made significant strides in regulatory harmonisation, ethical conduct in research, and capacity building for local researchers. It has also fostered partnerships between global pharmaceutical companies, local research institutions, and regulatory bodies, while showcasing the economic benefits of clinical trials, including job creation, increased investment, and technological development.
To date, the IAS has organised 11 workshops, eight forums, two scientific symposiums, and three conferences, featuring over 80 speakers, attracting 1,500 attendees, and engaging representatives from 13 regulatory bodies across SSA.
Xcene Research, the driving force behind the IAS, is committed to reshaping the clinical research landscape in Africa. As a leading Contract Research Organisation (CRO), it provides clinical trial management, data handling, and regulatory services. Additionally, the Xcene Research Academy was established to bridge the skills gap by training and empowering the next generation of African researchers, ensuring a sustainable pipeline of talent for the industry.
Through initiatives like the IAS, Xcene Research continues to leverage collaboration, innovation, and advocacy to position SSA as a key player in global healthcare advancements. By embracing clinical trials, the region can significantly contribute to the development of life-saving treatments, improve patient outcomes, and establish itself as a global healthcare hub.
 to play a more significant role in global clinical trials){kind=link}